Limited means you can get it, but your doctor has to file for prior approval first
The number one modifiable risk factor for sleep apnea is obesity, says Alcibiades Rodriguez, MD, medical director of the Comprehensive Epilepsy Center Sleep Center at NYU Langone
Studies of semaglutides long-term effects in overweight and obese people revealed several positive changes in health status, including: These changes are beneficial for long-term health and may reduce peoples risk of cardiovascular disease, type 2 diabetes, and stroke
Treatment should be discontinued if patients do not achieve at least 5% weight loss after 12 weeks on the maintenance dose
9 common questions. Accessed September 7, 2025
"Thankfully, this baby is super healthy." OZEMPIC AND WEGOVY WEIGHT LOSS DRUGS COULD HELP REDUCE ALCOHOL USE DISORDER SYMPTOMS, STUDY SUGGESTS Each pregnancy changed her body, Oliviara said, which was a "reminder of the losses." "I spent two years in the gym about four to five days a week working out," she said